Ipca Laboratories Ltd Quarterly Results

Gross Sales

2,308.85

2,246.69

2,245.37

2,354.9

2,092.63

Excise Duty

0

0

0

0

0

Net Sales

2,308.85

2,246.69

2,245.37

2,354.9

2,092.63

Other Operating Income

0

0

0

0

0

Other Income

32.66

25.82

20.11

26.26

20.61

Total Income

2,341.51

2,272.51

2,265.48

2,381.16

2,113.24

Total Expenditure

1,892.43

2,022.88

1,782.29

1,913.42

1,699.91

PBIDT

449.08

249.63

483.19

467.74

413.33

Interest

18.51

21.51

16.81

22.56

24.05

PBDT

430.57

228.12

466.38

445.18

389.28

Depreciation

100.06

100.12

98.46

100.35

98.89

Minority Interest Before NP

0

0

0

0

0

Tax

95.78

89.07

100.62

97.9

84.46

Deferred Tax

0.31

-26.85

-10.03

1.49

6.95

Reported Profit After Tax

234.42

65.78

277.33

245.44

198.98

Minority Interest After NP

-0.32

-3.83

28.22

16.27

6.9

Net Profit after Minority Interest

233.21

67.82

248.14

229.48

192.24

Extra-ordinary Items

0

-115.98

0

0

0

Adjusted Profit After Extra-ordinary item

233.21

183.8

248.14

229.48

192.24

EPS (Unit Curr.)

9.19

2.67

9.78

9.05

7.58

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

200

0

Equity

25.37

25.37

25.37

25.37

25.37

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

19.45

11.11

21.51

19.86

19.75

PBDTM(%)

18.64

10.15

20.77

18.9

18.6

PATM(%)

10.15

2.92

12.35

10.42

9.5